针对中小企业家的诉求，行业专家从政策解读、法治保障、市场运作等多维度提供深度解析与专业支 撑。"公平竞争是优化营商环境的核心要义。"工信部原中小企业司副司长王建翔围绕破除隐性壁垒、强 化政府采购支持中小企业发展等政策措施展开深入分析；中国中小商业企业协会科技总监鞠维刚聚焦金 融工具赋能科技成果转化，表示"科技成果不落地转化，便是沉睡的智力财富"；最高人民检察院检察听 证员孙莹就涉企刑事案件落实"少捕慎诉慎押"政策提出专业见解，认为"司法温度铸就企业信心，法治 护航方能行稳致远"。 与会代表委员结合自身履职领域作出积极回应与前瞻展望。全国人大代表、北京大学国际关系学院教授 李义虎从宏观战略视角，精准分析中小企业发展面临的机遇与挑战，表示"中小企业是国民经济的毛细 血管，是产业生态的关键一环，其活力直接关系经济大盘稳定"。全国政协委员王汝芳、曲永义分别结 合产业经济观察经验，就科技创新突破、产业升级路径、政策协同落地等提出前瞻性思考。(经济日报 记者敖蓉) 近日，由中国中小商业企业协会主办的"2026全国两会代表委员与中小企业座谈会"在北京举行。多位全 国人大代表、政协委员，以及政策研究、产业经济、法律、金融等领 ...

Group 1: Industry Overview - The fuel ethanol industry has formed a market-oriented competitive landscape, with pricing mechanisms influenced by international oil prices and competitive bidding processes [1] - The company holds a market share of over 30%, with annual sales of approximately 1.3 million tons, positioning it as a leader in the industry [2] Group 2: Cost Control and Raw Material Sourcing - The company reduces costs through diversified raw material procurement, including sourcing from cassava and expanding to Southeast Asia [2] - The company maintains high capacity utilization rates, often operating at or above full capacity [2] Group 3: Impact of Market Trends - The rapid development of electric vehicles exerts short-term pressure on the fuel vehicle market, but fuel vehicles are expected to retain a stable market share in the medium term [3] - The company views its fuel ethanol business as a foundational element while exploring new opportunities in downstream industrial applications [3] Group 4: Competitive Landscape - Coal-based ethanol is not considered a direct competitor as it falls under fossil energy, while fuel ethanol is derived from biomass [4] Group 5: Product Development and Profitability - The increase in gross margin for the starch sugar business since 2023 is attributed to a shift towards providing customized "solution-based" marketing services [5] - The company employs proprietary enzyme-catalyzed technology for allulose production, with plans to adjust capacity in line with market demand [6] - The allulose products have gained international recognition, with significant growth potential in the domestic market [6] Group 6: Project Updates - The company is accelerating the construction of its polylactic acid (PLA) project, with production expected to commence by the end of the first quarter [7]

Group 1: Industry Overview - The fuel ethanol industry has formed a market-oriented competitive landscape, with pricing mechanisms influenced by international oil prices and competitive bidding processes [1] - The company holds a market share of over 30%, with annual sales of approximately 1.3 million tons, positioning it as a leader in the industry [2] Group 2: Cost Control and Raw Material Sourcing - The company reduces costs through diversified raw material procurement, including sourcing from cassava and expanding to Southeast Asia [2] - The company maintains high capacity utilization rates, often operating at or above full capacity [2] Group 3: Impact of Market Trends - The rise of electric vehicles exerts short-term pressure on the fuel vehicle market; however, fuel vehicles are expected to retain a stable market share in the medium term [3] - The company views its fuel ethanol business as a foundational element while exploring new opportunities in downstream industrial applications [3] Group 4: Competitive Landscape - Coal-based ethanol is not considered a direct competitor as it falls under fossil energy, while fuel ethanol is derived from biomass [4] Group 5: Product Development and Profitability - The increase in profit margins for the starch sugar business since 2023 is attributed to a shift towards providing customized "solution-based" marketing services [5] - The company employs proprietary enzyme-catalyzed technology for allulose production, with plans to adjust capacity in line with market demand [6] - The allulose products have gained international recognition, with significant growth potential in the domestic market [6] Group 6: Project Updates - The company is accelerating the construction of its polylactic acid (PLA) project, with production expected to commence by the end of the first quarter [7]

2026年1月29日，新浪财经、第一财经与古井贡酒·年份原浆古20共同携手举办的"为中国经济点赞——企业家之夜"在北京正大中心举行。 这不仅仅是一场年度荣誉盛宴，更是一扇观察中国经济韧性、多元动力与未来方向的窗口。透过企业家们的感言、洞察与愿景，我们得以窥见中国经济在承 压前行中，那些坚实而蓬勃的驱动力。 基石的力量，传统产业的升级与自信 当紫金矿业创始人陈景河在回顾企业成长视频时悄然落泪，全场为之动容。这泪水，不仅是个体创业艰辛与荣耀的抒发，更是中国基础产业在全球竞争中逆 势崛起的缩影。 陈景河直言，西方公司曾控制最优质的矿业资源，但紫金凭借完整的技术能力、强大的探矿能力和每一位艰苦卓绝、富有奉献精神的紫金人，实现了"所向 披靡"。他从一个县级小企业起步，到将海外黄金板块成功分拆上市，市值瞩目，其自信宣言——"现在想不发财都很难"，背后是中国矿业企业在技术、管 理、国际化运营上累积的深厚内功。 智谱董事长刘德兵谈及其AGI（通用人工智能）愿景："让机器像人一样思考"，代表了在人工智能基础层追求终极境界的雄心。小马智行彭军则通过实时连 线无人驾驶车，展现了十年专注Robotaxi，让未来出行更安全高效的务实路 ...

Group 1 - The core viewpoint of the articles is that Capbio (300639) has obtained five invention patents in January 2026, which enhance the company's intellectual property strength and product competitiveness in the fields of bioengineering, microdroplet generation, cell sorting, and nucleic acid testing [1][2] Group 2 - The patents include methods and systems for hybrid analysis, microdroplet generation, live cell sorting, sample preservation, and sample division, which have been authorized in China and Brazil [1] - The patented technologies address industry pain points, such as improving detection accuracy, ensuring consistent droplet volume, increasing sorting accuracy, and effectively preserving viral nucleic acids at room temperature for up to 16 days [1] Group 3 - Capbio aims to become a leading enterprise in nucleic acid molecular diagnostics and is advancing its "Nucleic Acid 99" strategy, which aligns with its development strategy and enhances its core competitiveness [2]

Core Viewpoint - Jiangsu Kangwei Century Biotechnology Co., Ltd. announced the retirement of its internal audit department head, Mr. Tang Yufeng, who will no longer hold any position in the company after his departure [1]. Group 1 - The board of directors received a written resignation report from Mr. Tang Yufeng due to retirement [1]. - Mr. Tang's resignation will take effect upon delivery to the board of directors, and it will not impact the company's normal operations [1]. - The board expressed gratitude for Mr. Tang's contributions during his tenure [1].

Group 1 - The company, Shanghai Zhijiang Biological Technology Co., Ltd., has approved a share repurchase plan to buy back shares using its own funds and a special loan for stock repurchase, with a maximum price of RMB 37.99 per share and a total repurchase amount between RMB 60 million and RMB 120 million [2][4] - The repurchase period is set for 12 months from the date of board approval, which was on October 15, 2025 [2][4] Group 2 - As of January 2026, the company has repurchased a total of 1,940,434 shares, representing 1.01% of the current total share capital of 192,157,999 shares, with a total expenditure of RMB 41,869,022.21 [3] - The highest and lowest prices for the repurchased shares were RMB 23.49 and RMB 19.58 per share, respectively [3]

Core Insights - The biotechnology industry is rapidly developing and is a key direction for global technological revolution and industrial upgrading, with innovative drugs being a core engine aligned with the "Healthy China" strategy [1] - By 2026, the Hong Kong stock market's biotechnology sector is expected to see a significant increase in merger and acquisition activities, with Goldman Sachs predicting record-high global pharmaceutical and biotechnology M&A volumes [1] - The Chinese biotechnology sector is currently driven by a combination of policy benefits, capital support, and technological breakthroughs, with a shift in regulatory focus from cost control to encouraging quality innovation [1][2] Industry Trends - There is a persistent demand for the diagnosis and treatment of diseases such as cancer and cardiovascular conditions, supported by increased consumer payment capacity and rising healthcare expenditures, providing substantial growth opportunities for the industry [2] - The industry is transitioning from "broad innovation" to "differentiated innovation and international development," with a significant number of innovative drugs expected to be approved in China by 2025 [2] - In 2025, 76 innovative drugs are projected to be approved in China, with over 80% being domestic innovations, and a record total of over $130 billion in licensing transactions for innovative drugs [2] Investment Opportunities - The Hang Seng Biotechnology Index (HSBIO.HI) highlights the investment value of high-purity and scarce biotechnology companies, focusing on leading firms in the sector with a low overlap with traditional pharmaceuticals [3] - The index includes 30 leading biotechnology companies listed in Hong Kong, with a significant portion of its weight concentrated in the top ten stocks, including WuXi Biologics and BeiGene [3] - The Guangfa Hang Seng Biotechnology ETF, launched to facilitate efficient investment in core biotechnology assets, offers T+0 trading and low fees, positioning it as an attractive option for investors looking to capitalize on the sector's growth [3][4]

近年来，江宁区深入实施乡村振兴战略，以产业发展为核心，以智慧农业为驱动，以和美乡村建设为抓 手，全面推进农业农村现代化。全区粮食生产稳中有进，特色农业提质增效，数字技术深度融合，乡村 面貌焕然一新，走出了一条具有江宁特色的高质量发展之路。江宁乡村治理、乡村振兴成功入选全国典 型案例，先后获得全国宜居宜业典范区、全国休闲农业和乡村旅游示范区、全国文化产业赋能乡村振兴 试点区、国家级水产健康养殖和生态养殖示范区等多项国家级荣誉。 今年，江宁区将打造10个以上乡村运营试点村，推行村集体自主运营、聘请乡村CEO、专业化运营企业 整片运营、国企统一运营4种运营模式。到2028年，力争引育3家引领型专业化运营企业、100名乡村 CEO和6000名青年人才，重点村组团片区实现整体运营，基本建成"业态融合、多元赋能、价值转化、 利益联结"的现代化乡村运营体系。 会上，江宁区乡村振兴招商平台——"江宁村品汇"正式上线。该平台由江宁区农业农村局联合江宁区休 闲农业协会打造，包含"走进江宁""休闲农旅""共享小院""政策指引"等内容，让江宁优质资源与发展商 机触手可及。 23个项目在会议现场集中签约，总投资超20亿元，涵盖农业产业 ...

Core Insights - The "Hai Gui Chuang Xiang • Zhi Hui Jiang Chuan" summit gathered over 120 returnee alumni and guests from Shanghai Jiao Tong University and Tsinghua University, creating a high-end platform for innovation and entrepreneurship among returnee talents [3][5] - The event included a pairing ceremony for returnee alumni to support community projects, establishing professional guidance partnerships in various fields such as art, enterprise services, investment promotion, green low-carbon initiatives, and community development [3][5] Group 1 - The summit was co-hosted by the Shanghai Overseas-Returned Scholars Association and the alumni associations of Shanghai Jiao Tong University and Tsinghua University, emphasizing the dual commitment of talents and regions [5] - The leaders from Minhang District expressed hopes for returnee alumni to become leaders in industrial upgrading, liaisons for open cooperation, and representatives of urban quality, aiming to transform Minhang into a home for returnee talents [5][7] - The summit featured three dialogue sessions focusing on "Reconstructing the Entrepreneurial Skyline," "Reconstructing the Research Skyline," and "Reconstructing the Investment Skyline," facilitating in-depth discussions [5][7] Group 2 - Entrepreneurs like Xu Jianhe from Baifuan Biotechnology and Li Yifan from Hesai Technology shared their experiences in tech entrepreneurship during the entrepreneurial dialogue session [7] - Top scholars discussed the integration of basic research and technological innovation, with insights from foreign academicians and researchers [7] - Zhang Wanbin, an academician from the Chinese Academy of Sciences, presented on "Green Intelligent Manufacturing of Chiral Drugs," showcasing successful transitions from laboratory research to production, highlighting the contributions of returnee scholars to public health and industrial development [7][8] Group 3 - The organizers stated that the summit deepened the friendship and cooperation between the alumni of Tsinghua and Jiao Tong universities, establishing an innovative bridge for collaboration between academia and industry [8] - The alumni associations plan to continue their role as a bridge, harnessing the wisdom of returnees to advance technological innovation and contribute to the high-quality development of the regional economy and society [8]